ProQR Therapeutics NV (NASDAQ:PRQR)

0.8532
Delayed Data
As of Aug 12
 +0.0382 / +4.69%
Today’s Change
0.53
Today|||52-Week Range
9.09
-89.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization524.5K1.4M1.2M1.1M
 
 
 
 
 
 
Operating ExpensesGross Income-524.5K-1.4M-1.2M-1.1M
 
 
 
 
 
General Expenses33.0M44.4M46.2M48.5M
 
 
 
 
 
Research And Development25.5M34.3M34.2M34.6M
 
 
 
 
 
Total Operating Expenses33.5M45.8M47.4M49.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.5M-45.8M-47.4M-49.6M
 
 
 
 
 
Interest Expense On Debt438.0K595.1K672.2K955.6K
 
 
 
 
 
Other Expenses10.3M2.8M-1.3M6.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.1M-43.3M-49.3M-43.8M
 
 
 
 
 
Income Taxes0.000.00-2.3K-1.2K
 
 
 
Minority Interest0.000.00-42.9K-226.5K
 
 
 
Net Income-23.1M-43.3M-49.2M-43.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.3M23.3M25.4M34.1M
 
 
 
 
 
Shares To Calculate EPS Diluted23.3M23.3M25.4M34.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.99-$1.86-$1.94-$1.27
 
 
 
 
 
EPS Diluted-$0.99-$1.85-$1.94-$1.28